The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre.
Bladder cancer
Histological variants
Mixed variants
Radical cystectomy
Urothelial carcinoma
Journal
World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
30
04
2020
accepted:
11
07
2020
pubmed:
23
7
2020
medline:
28
9
2021
entrez:
23
7
2020
Statut:
ppublish
Résumé
To evaluate the impact of histological variants on oncological outcomes of patients with muscle-invasive bladder cancer treated with open radical cystectomy and furthermore to determine any association between survival and each histotype of bladder cancer. Data from 525 consecutive patients with muscle-invasive bladder cancer treated with radical cystectomy between January 2008 and May 2019 were collected retrospectively. The Kaplan-Meier curves and multivariable analysis addressed the role of histological variants in recurrence, cancer-specific and overall mortality between all subgroups. Of 525 patients, 131 (25.0%) showed a histological variant at radical cystectomy. With a median follow-up of 31 months, 209 (39.8%) recurrences, 184 (35.0%) cancer-related deaths and 260 (49.5%) overall deaths were reported. The presence of histological variant was associated with advanced tumour stage, the presence of concomitant carcinoma in situ, lymph node metastasis, lymphovascular invasion and positive surgical margins compared to pure urothelial bladder cancer (all p values < .008) and resulted as an independent risk factor for cancer-specific mortality (p = 0.001). Patients with a histological variant were at significantly higher risk for recurrence, cancer-specific mortality and overall mortality (all p values ≤ .001). Micropapillary, sarcomatoid or small cell differentiation was associated with reduced survival. The presence of histological variants at radical cystectomy seems to be weakly associated with reduced survival compared to pure urothelial bladder cancer paired for pathologic stage. The association of histological variants with advanced and biologically aggressive tumours suggests the need for attention on the overall management of these patients, in particular for micropapillary, sarcomatoid and small cell differentiation.
Identifiants
pubmed: 32696127
doi: 10.1007/s00345-020-03364-z
pii: 10.1007/s00345-020-03364-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1917-1926Références
Moschini M, Dell’Oglio P, Luciano R et al (2017) Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy. Urol Oncol Semin Orig Investig 35:335–341
Chalasani V, Chin JL, Izawa JI (2009) Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. Can Urol Assoc J 3(6 Suppl 4):S193–S198. https://doi.org/10.5489/cuaj.1195
doi: 10.5489/cuaj.1195
pubmed: 20019984
pmcid: 2792446
Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-part b: prostate and bladder tumours. Eur Urol 70(1):106–119. https://doi.org/10.1016/j.eururo.2016.02.028
doi: 10.1016/j.eururo.2016.02.028
pubmed: 26996659
Black PC, Brown GA, Dinney CP (2009) The impact of variant histology on the outcome of bladder cancer treated with curative intent. Urol Oncol 27(1):3–7. https://doi.org/10.1016/j.urolonc.2007.07.010
doi: 10.1016/j.urolonc.2007.07.010
pubmed: 18367107
Motterle G, Andrews JR, Morlacco A, Karnes RJ (2019) Predicting response to neoadjuvant chemotherapy in bladder cancer. Eur Urol Focus Elsevier B.V.
Vetterlein MW, Wankowicz SAM, Seisen T et al (2017) Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology. Cancer 123:4346–4355
doi: 10.1002/cncr.30907
Pokuri VK, Syed JR, Yang Z et al (2016) Predictors of complete pathologic response (pT0) to neoadjuvant chemotherapy in muscle-invasive bladder carcinoma. Clin Genitourin Cancer 14(1):e59–e65. https://doi.org/10.1016/j.clgc.2015.09.013
doi: 10.1016/j.clgc.2015.09.013
pubmed: 26508364
Necchi A, Raggi D, Gallina A et al (2020) Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies. Eur Urol 77(4):439–446. https://doi.org/10.1016/j.eururo.2019.10.026
doi: 10.1016/j.eururo.2019.10.026
pubmed: 31708296
Veskimäe E et al (2019) What is the prognostic and clinical importance of urothelial and nonurothelial histological variants of bladder cancer in predicting oncological outcomes in patients with muscle-invasive and metastatic bladder cancer? A European association of urology muscle invasive and metastatic bladder cancer guidelines panel systematic review European urology oncology. NLM (Medline). https://doi.org/10.1016/j.euo.2019.09.003
doi: 10.1016/j.euo.2019.09.003
Paner GP, Stadler WM, Hansel DE, Montironi R, Lin DW, Amin MB (2018) Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur Urol 73(4):560–569. https://doi.org/10.1016/j.eururo.2017.12.018
doi: 10.1016/j.eururo.2017.12.018
pubmed: 29325693
Dorin RP, Daneshmand S, Eisenberg MS et al (2011) Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol 60(5):946–952. https://doi.org/10.1016/j.eururo.2011.07.012
doi: 10.1016/j.eururo.2011.07.012
pubmed: 21802833
EAU Guidelines Office, Arnhem, The Netherlands. https://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic/ accessed 14 April 2020
Wheat JC, Weizer AZ, Wolf JS et al (2012) Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol Semin Orig Investig 30:252–258
Lotan Y, Gupta A, Shariat SF et al (2005) Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23:6533–6539
doi: 10.1200/JCO.2005.05.516
Novara G, Svatek RS, Karakiewicz PI et al (2010) Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4400 patients. J Urol 183(6):2165–2170. https://doi.org/10.1016/j.juro.2010.02.021
doi: 10.1016/j.juro.2010.02.021
pubmed: 20399473
Lobo N, Shariat SF, Guo CC et al (2019) What Is the significance of variant histology in urothelial carcinoma? Eur Urol Focus Press. https://doi.org/10.1016/j.euf.2019.09.003
doi: 10.1016/j.euf.2019.09.003
Montironi R, Lopez-Beltran A (2005) The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 13(2):143–153. https://doi.org/10.1177/106689690501300203
doi: 10.1177/106689690501300203
pubmed: 15864376
Leissner J, Hohenfellner R, Thüroff JW, Wolf HK (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85(7):817–823. https://doi.org/10.1046/j.1464-410x.2000.00614.x
doi: 10.1046/j.1464-410x.2000.00614.x
pubmed: 10792159
van de Fransen Putte EE, Hermans TJ, Werkhoven Ev et al (2015) Lymph node count at radical cystectomy does not influence long-term survival if surgeons adhere to a standardized template. Urol Oncol. https://doi.org/10.1016/j.urolonc.2015.08.001 (33(12): 504.e19–504.e5.04E24)
doi: 10.1016/j.urolonc.2015.08.001
Xylinas E, Rink M, Robinson BD et al (2013) Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. Eur J Cancer 49(8):1889–1897. https://doi.org/10.1016/j.ejca.2013.02.001
doi: 10.1016/j.ejca.2013.02.001
pubmed: 23466126
Soave A, Schmidt S, Dahlem R et al (2015) Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy? Urol Oncol 33(1):21.e1–21.e9. https://doi.org/10.1016/j.urolonc.2014.10.013
doi: 10.1016/j.urolonc.2014.10.013
Molina-Cerrillo J, Martínez-Sáez O, Alonso-Gordoa T et al (2015) Primary sarcomatoid tumor of the bladder: a different entity but the same approach? Clin Genitourin Cancer 13(6):493–498. https://doi.org/10.1016/j.clgc.2015.05.001
doi: 10.1016/j.clgc.2015.05.001
pubmed: 26027772
Wang J, Wang FW, Lagrange CA, Hemstreet GP III, Kessinger A (2010) Clinical features of sarcomatoid carcinoma (carcinosarcoma) of the urinary bladder: analysis of 221 cases. Sarcoma 2010:454792. https://doi.org/10.1155/2010/454792
doi: 10.1155/2010/454792
pubmed: 20706685
pmcid: 2913791
Minato A, Noguchi H, Tomisaki I et al (2018) Clinical significance of squamous differentiation in urothelial carcinoma of the bladder. Cancer Control 25(1):1073274818800269
doi: 10.1177/1073274818800269
Mitra AP, Bartsch CC, Bartsch G Jr, Miranda G, Skinner EC, Daneshmand S (2014) Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis. Urol Oncol 32(2):117–127. https://doi.org/10.1016/j.urolonc.2012.08.017
doi: 10.1016/j.urolonc.2012.08.017
pubmed: 23477878
Izard JP, Siemens DR, Mackillop WJ et al (2015) Outcomes of squamous histology in bladder cancer: a population-based study. Urol Oncol 33(10):425.e7–425.e13. https://doi.org/10.1016/j.urolonc.2015.06.011
doi: 10.1016/j.urolonc.2015.06.011
Wang G, Xiao L, Zhang M et al (2018) Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases. Hum Pathol 79:57–65. https://doi.org/10.1016/j.humpath.2018.05.005
doi: 10.1016/j.humpath.2018.05.005
pubmed: 29763719
pmcid: 6133751
Amin MB (2009) Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications. Mod Pathol 22(Suppl 2):S96–S118. https://doi.org/10.1038/modpathol.2009.26
doi: 10.1038/modpathol.2009.26
pubmed: 19494856
Kamat AM, Gee JR, Dinney CP et al (2006) The case for early cystectomy in the treatment of non muscle invasive micropapillary bladder carcinoma. J Urol 175(3 Pt 1):881–885. https://doi.org/10.1016/S0022-5347(05)00423-4 (published correction appears in J Urol. 2006 May; 175(5): 1967)
doi: 10.1016/S0022-5347(05)00423-4
pubmed: 16469571
Abdollah F, Sun M, Jeldres C et al (2012) Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs. urothelial carcinoma: a competing-risks analysis. BJU Int 109(4):564–569. https://doi.org/10.1111/j.1464-410X.2011.10357.x
doi: 10.1111/j.1464-410X.2011.10357.x
pubmed: 21810161